a new way to b study b how b cannabis b use

A new way to study how cannabis use impacts safe driving | EurekAlert!

✦ New
CED Clinical Relevance
#62 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
SafetyResearchPolicyTHCDosing
Why This Matters
If you use cannabis medicinally and drive, better research into impairment testing could eventually replace unreliable THC blood level thresholds with assessments that more fairly and accurately reflect whether you are actually safe behind the wheel.
Clinical Summary

As cannabis legalization continues to expand across the United States, research into how cannabis use affects driving performance remains critically underdeveloped, creating a significant gap between policy and patient safety evidence. New approaches to studying cannabis-impaired driving are essential because unlike alcohol, THC affects psychomotor function in highly variable ways depending on tolerance, dosing method, cannabinoid profile, and individual metabolism. Clinically, we need validated tools that reflect real-world impairment rather than relying solely on blood THC levels, which correlate poorly with actual functional impairment.

Dr. Caplan’s Take
“We have been punishing patients based on a blood THC number that tells us almost nothing about whether they can safely operate a vehicle, and it is long past time that science caught up with the policy we are already living under.”
Clinical Perspective

🔬 New research methodologies are being developed to better understand how cannabis actually affects driving, and this matters enormously for patients. For years, we have relied on blood THC levels as a proxy for impairment, but clinically I can tell you that a daily medical cannabis patient with stable tolerance and a THC-naive recreational user are worlds apart in terms of functional impairment. ️ The legal system has largely treated them the same, which is neither scientifically sound nor fair. What we need are validated, real-world impairment assessments that account for tolerance, route of administration, cannabinoid ratios, and individual pharmacokinetics. This kind of research is exactly what responsible legalization demands, and I am encouraged to see it getting the attention it deserves.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →